PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of springeropenLink to Publisher's site
The Journal of Physiological Sciences
 
J Physiol Sci. 2016; 66: 275–282.
Published online 2015 November 19. doi:  10.1007/s12576-015-0425-0
PMCID: PMC4893072

Somato-axodendritic release of oxytocin into the brain due to calcium amplification is essential for social memory

Abstract

Oxytocin (OT) is released into the brain from the cell soma, axons, and dendrites of neurosecretory cells in the hypothalamus. Locally released OT can activate OT receptors, form inositol-1,4,5-trisphosphate and elevate intracellular free calcium (Ca2+) concentrations [(Ca2+)i] in self and neighboring neurons in the hypothalamus, resulting in further OT release: i.e., autocrine or paracrine systems of OT-induced OT release. CD38-dependent cyclic ADP-ribose (cADPR) is also involved in this autoregulation by elevating [Ca2+]i via Ca2+ mobilization through ryanodine receptors on intracellular Ca2+ pools that are sensitive to both Ca2+ and cADPR. In addition, it has recently been reported that heat stimulation and hyperthermia enhance [Ca2+]i increases by Ca2+ influx, probably through TRPM2 cation channels, suggesting that cADPR and TRPM2 molecules act as Ca2+ signal amplifiers. Thus, OT release is not simply due to depolarization–secretion coupling. Both of these molecules play critical roles not only during labor and milk ejection in reproductive females, but also during social behavior in daily life in both genders. This was clearly demonstrated in CD38 knockout mice in that social behavior was impaired by reduction of [Ca2+]i elevation and subsequent OT secretion. Evidence for the associations of CD38 with social behavior and psychiatric disorder is discussed, especially in subjects with autism spectrum disorder.

Keywords: Oxytocin, Hypothalamus, Social behavior, CD38, TRPM2

Introduction

Oxytocin (OT) and arginine vasopressin (AVP) are nonapeptides that differ in two amino acid residues [1]. OT and AVP are synthesized mostly in distinct neurons in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) in the hypothalamus [2, 3]. OT and AVP are secreted into the blood circulation and have physiological roles in peripheral organs, such as the uterus, mammary gland, and kidney. They induce contraction of uterine and mammary duct smooth muscle or diuretic action in the kidney as hormones [46].

OT, AVP, and their receptors are present in the brain not only in females during specific reproductive periods but also in non-reproductive females and males [6]. Accumulating evidence has established that, in addition to classical hormonal functions, both peptides play critical roles in social recognition and social behavior in mammals, including humans [720]. This review focuses mainly on OT. The main point is not a general functional role of OT in a comprehensive review, but the molecular mechanisms of OT secretion into the brain that is critical in the neuronal function of OT in social recognition and behavior [4, 11, 13, 21].

Another reason to focus on the release is that the mechanism contains a very important aspect in terms of physiological science, in that the proposed idea challenges the principal rule in physiology of depolarization–secretion coupling [2224]. Furthermore, this mechanism seems to have a potential relationship to autism spectrum disorder (ASD), a serious developmental disorder, which is a rapidly advancing field in neuroscience and psychiatry and is a serious disorder in our society [2528]. There have been many reviews regarding the relationship between ASD and OT [2935]. However, there have been few regarding the molecular mechanism of OT release into the brain [4], which is the critical step for social recognition and social behavior [2628].

Somato-axodendritic release of oxytocin

OT is secreted from the nerve terminals of axons of oxytocinergic neurons at the perivascular site in the posterior lobe of the pituitary into the circulation [4] (Fig. 1). Oxytocinergic neurons send their axons to the amygdala and some other limited brain regions and secrete OT from the nerve terminals [4, 12, 15]. It is known that adrenaline stimulates oxytocinergic neurons in the SON, which results in local release of OT in the brain [5, 36]. This release occurs from the cell soma, axons, and dendrites, i.e., somato-axodendritic release [3739].

Fig. 1
Electron micrographs of the posterior pituitary glands of wild-type (a) and CD38 knockout (b) mice. Vesicles are nerve endings close to the vascular space (V). Most of the dense core vesicles are oxytocinergic, as determined by immunoelectron microscopic ...

Locally released OT causes excitation of OT neurons by activating OT receptors expressed in neurons of both the PVN and SON [4043]. OT stimulates OT receptors and facilitates OT release from the stimulated neurons. Released OT can stimulate OT receptors and elicits release from the same neurons (autocrine) or nearby neurons (paracrine) [44] (Fig. 2). This OT-induced OT release determines the basal brain concentrations and elevated concentrations of OT. The concept of autoregulation, OT-induced OT release, can be an extremely efficient way to achieve massive OT recruitment during uterine contraction in labor and milk ejection in lactation [5, 6, 4547]. Autoregulation, however, is also an essential brain mechanism for social recognition in daily life in both genders, as proposed previously [25, 27, 28].

Fig. 2
Scheme showing autocrine and paracrine release of oxytocin. OT is released from dendrites (dendritic release), from the cell soma (soma release), and from axons (axonal release) in the hypothalamus. Hypothalamic oxytocinergic neurons express OT receptors ...

Oxytocin receptors and cellular signaling

OT receptors are seven-transmembrane proteins that couple with the Gq/11-type GTP-binding protein [48]. Stimulation of OT receptors leads to the production of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) through the activation of phospholipase C (PLC) [48]. This results in activation of Ca2+ mobilization from IP3-sensitive Ca2+ pools [49].

On the other hand, another Ca2+ signal pathway of cyclic ADP-ribose (cADPR) [50, 51] was identified downstream of OT receptors [11]. cADPR mobilizes Ca2+ through cADPR-sensitive Ca2+ pools, in a mechanism referred to as Ca2+-induced Ca2+ release. In this process, cADPR plays an essential role in mobilizing Ca2+ through Ca2+ channels of ryanodine receptors [5256] (Fig. 3). The recent review by Leng et al. did not mention this cADPR/CD38 hypothesis [4], probably because they described by their data based on their finding with thapsigargin [36].

Fig. 3
Intracellular signaling pathways leading to increased cyclic ADP-ribose formation. Phosphorylation (P) of ADP-ribosyl cyclase (pink) is mediated by several pathways. Nitric oxide (NO), cyclic GMP (cGMP), and protein kinase G (G-kinase); acetylcholine ...

It is known that intracellular cADPR concentrations are regulated in many different ways, including activation of ADP-ribosyl cyclase or CD38, via heterotrimeric GTP-binding proteins, or phosphorylation downstream of the G protein-coupled receptor signaling pathways [5759]. Specifically, the activation of ADP-ribosyl cyclase or CD38 by cyclic GMP- or cyclic AMP-dependent protein kinases has been reported in Aplysia californica, liver cells [60, 61], LAK cells [62, 63], and artery smooth muscle cells [57] (Fig. 3).

cADPR is a catalytic product of ADP-ribosyl cyclase or ectopic CD38 [50, 51, 63] (Fig. 4). cADPR is produced in the extracellular space by the large C-terminal portion of CD38 with catalytic activity that may be present in the extracellular space. Therefore, it is unclear how extracellular cADPR produced by CD38 acts as an intracellular second messenger. It has been reported that cADPR applied extracellularly stimulates intracellular ryanodine receptors after internalization by the nucleotide-transporting capacity of CD38 in fibroblasts and astrocytes (the nucleotide carrier hypothesis of De Flora) [64, 65]. Recently, it was reported that the type II transmembrane glycoprotein, CD38, may exist in two forms with regard to membrane topology [66, 67]; the large C-terminal portion with catalytic activity may exist in the extracellular space as the type II protein, and this catalytic site may also exist inside the cell as the type III form (Fig. 4a). In the latter case, the product of CD38, cADPR, is produced intracellularly, and acts directly as a second messenger (two topology hypothesis of Lee).

Fig. 4
Membrane topology and enzyme reaction of CD38. CD38 (pink oval) usually forms a dimer. β-NAD+ binds to the central catalytic site of CD38. The large C-terminal part is located in the extracellular space, as the type II transmembrane protein, or ...

Effects of oxytocin on ADP-ribosyl cyclase and intracellular Ca2+ concentrations

Application of OT stimulates ADP-ribosyl cyclase activity or CD38 in crude membrane fractions, when measured by cADPR formation from β-NAD+ or by cyclic GDP-ribose (cGDPR) production from NGD+ [50, 68]. cADPR or cGDPR production increases in a concentration-dependent manner upon exposure to sub-nanomolar concentrations of OT [49].

Subsequently, in isolated hypothalamic neurons, application of 100 pM OT results in [Ca2+]i increases: a rapid initial increase and a sustained elevation lasting for 5 min [69]. OT elicits an initial elevation of the maximum [Ca2+]i, and this phase is IP3-dependent. Pretreatment with 8-bromo-cADPR, an antagonist of the cADPR-binding site of Ca2+ release channels of ryanodine, inhibits OT-mediated sustained [Ca2+]i increases. ADPR and β-NAD+ also induce elevation of [Ca2+]i and replicate the second phase of sustained [Ca2+]i increases [49, 69]. Under Ca2+-free conditions, the OT-mediated increase of [Ca2+]i shows little change in either phase, suggesting that the two phases of [Ca2+]i elevation in hypothalamic neurons are due to Ca2+ mobilization from the intracellular Ca2+ pools [49].

Oxytocin release by extracellular application of cyclic ADP-ribose

High potassium-induced depolarization produces an increase of up to eightfold in OT secretion from isolated mouse hypothalamic neurons or their axon terminals in the posterior pituitary gland, respectively [21]. OT release is enhanced by about fourfold by application of extracellular β-NAD+, a precursor of cADPR (refer to Fig. 4 in [21]). The increase is blocked completely by 8-bromo-cADPR. To further confirm the involvement of cADPR, we examined the effects of extracellular application of several β-NAD+ metabolites [49, 69]. Only cADPR showed a potentiation effect, indicating that OT release utilizes the cADPR/ryanodine calcium amplification system (Fig. 5).

Fig. 5
Oxytocin induced oxytocin release. Oxytocin (OT; yellow circles) stimulates oxytocin receptors (OTR). Subsequently, the Gq/11 type G protein and phospholipase C (PLC) are activated, resulting in formation of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol ...

Involvement of TRPM2 channels

Melastatin-related transient receptor potential channel 2 (TRPM2, previously named TRPC7 or LTRPC2) possesses ADPR hydrolase activity and is a Ca2+-permeable cation channel. β-NAD+, ADPR, and cADPR can activate TRPM2 channels [70]. TRPM2 activation by cADPR is promoted at body temperature (>35 °C) and is involved in insulin secretion in pancreatic β cells [71]. In addition, TRPM2 channels are related to receptor functions through cADPR formation [72].

Extracellularly applied cADPR can activate [Ca2+]i signaling via CD38 or TRPM2 channels downstream of OT receptors. [Ca2+]i increases in the model neuron, NG108-15 mouse neuroblastoma × rat glioma hybrid cells that possess CD38 [58, 73] but not OT receptors [74], as in the isolated whole hypothalamus after stimulation with extracellularly applied cADPR [69, 75]. Interestingly, the same tissues show significantly greater increases upon extracellular challenge with cADPR together by heating to 40 °C from 35 °C in the incubation medium (Fig. 6). Little or no cADPR-mediated [Ca2+]i elevation was observed at 40 °C in the absence of extracellular Ca2+. Ca2+ influx is expected, probably through non-selective cation TRPM2 channels, because elevation of [Ca2+]i is inhibited by the TRPM2 channel inhibitor, 2-aminoethoxydiphenyl borate (2-APB). Similarly, 8-bromo-cADPR inhibits responses to β-NAD+ and heat. These results suggest that cADPR contributes to both Ca2+ mobilization from internal Ca2+ pools and Ca2+ influx through TRPM2 Ca2+-permeable channels from the extracellular space. Such [Ca2+]i increases may result in OT release. However, there have been no previous reports regarding heat-induced OT release in the hypothalamus.

Fig. 6
Effects of cyclic ADP-ribose, ADP-ribose, and β-NAD+ on heat-induced calcium concentration rise. Time course of [Ca2+]i changes in Oregon Green-induced anterior hypothalamic neurons. At about 25 s after the beginning of each trace, cells ...

Contribution of CD38

In the central nervous system, ADP-ribosyl cyclase activity corresponding to CD38 is detected as early as embryonic day 15 in mouse development [76]. In the brain, expression levels of CD38 and ADP-ribosyl cyclase activity increase with further development [77]. The role of CD38 in regulation of OT secretion through cADPR-mediated intracellular calcium signaling has been clearly demonstrated using CD38 knockout mice [11, 21, 78, 79]. The plasma and cerebrospinal fluid OT levels are reduced in CD38 knockout mice. Electron microscopic examination exhibited little to no release from the nerve endings of oxytocinergic neurons in the pituitary of CD38 knockout mice (Fig. 1). These phenotypes were rescued by simple subcutaneous injection of OT as well as brain local re-expression of human CD38, but not mutant CD38, by the lentivirus infection method in CD38 knockout mice [21].

Human social behavior and psychiatric disorders

As CD38 is recognized as being closely related to OT release and social memory in mice, we examined the association of single nucleotide polymorphisms (SNPs) in the human CD38 gene on ASD [80]. In a series of elegant studies in 323 mothers, fathers, and non-parents, Epstein and colleagues reported that risk alleles on CD38 (including rs3796863) genes are associated with less parental touch. In contrast, relatively high plasma OT levels in subjects with low-risk CD38 alleles predict longer durations of parent–infant gaze synchrony. Furthermore, parents that display more touch toward their infants were reported to have been well cared for in childhood, to exhibit higher plasma to levels, and to have low-risk CD38 alleles [29, 30, 81]. The mother’s CD38 allele predicts parental behavioral synchrony at 1 and 6 months of their first-born infants and children’s social reciprocity during interactions with their best friend at 3 years. CD38 in the OT pathway was shown to be critical for parent–infant attachment and attention [82]. A SNP on the CD38 gene is also associated with social integration and social connectedness [83].

Several studies indicated the association of CD38 with ASD [8487]. Ten SNPs and mutations of CD38 were examined, and the CD38 SNPs, rs6449197 and rs3796863, were shown to be linked with high-functioning ASD in participants in the USA but not in Japan. These findings were partially replicated among Israeli subjects [29, 31, 32, 87].

Conclusion

This review discussed how OT is released into the brain. Ca2+ influx through Ca2+ channels is not sufficient to trigger OT release. The Ca2+ signal must be amplified by Ca2+-induced Ca2+ release through Ca2+ channels of ryanodine receptors type II or III by cADPR and some NAD metabolites in the hypothalamus (Fig. 7). In addition, Ca2+ influx through TRPM2 channels contribute more to increases in [Ca2+]i. This hypothesis of depolarization-independent but heat-sensitive Ca2+ signaling for OT release is consistent with the previous suggestion of dendritic release of OT without depolarization [4, 21, 39].

Fig. 7
Scheme indicating Ca2+ amplification with different ryanodine receptor subtypes. Skeletal muscle contraction and heart muscle contraction utilize type I and II ryanodine receptors, respectively. Oxytocin release uses type II or III ryanodine receptors ...

OT exerts an anxiolytic effect during stress, and stress sometimes induces hyperthermia. It is therefore interesting to examine how stress induces hyperthermia, which results in subsequent OT release. OT release seems to be important in damping the stress-induced disadvantage.

OT is an essential molecule for social memory and social behavior [21, 29]. Deficiency in social behavior is the core symptom of ASD. Recently, Yamasue and his group reported that repetitive intranasal OT administration for 6 weeks improved symptoms of the social behavior domain [88]. This result could be due to the delivery of OT to the brain by intranasal administration, but there is still little direct evidence regarding whether OT is recruited into the brain from the peripheral tissues or organs crossing the blood–brain barrier from the blood circulation. Several important questions regarding OT secretion into the brain and OT-induced Ca2+ signaling and OT transport from the blood to the brain remain to be resolved.

Acknowledgments

This work was supported by a grant-in-aid from Integrated Research on Neuropsychiatric Disorders carried out under the Strategic Research Program for Brain Sciences.

References

1. Hoyle CH. Neuropeptide families: evolutionary perspectives. Regul Pept. 1998;73(1):1–33. doi: 10.1016/S0167-0115(97)01073-2. [PubMed] [Cross Ref]
2. Gainer H. Cell-type specific expression of oxytocin and vasopressin genes: an experimental odyssey. J Neuroendocrinol. 2012;24(4):528–538. doi: 10.1111/j.1365-2826.2011.02236.x. [PMC free article] [PubMed] [Cross Ref]
3. Katoh A, et al. Highly visible expression of an oxytocin-monomeric red fluorescent protein 1 fusion gene in the hypothalamus and posterior pituitary of transgenic rats. Endocrinology. 2011;152(7):2768–2774. doi: 10.1210/en.2011-0006. [PubMed] [Cross Ref]
4. Leng G, et al. 60 years of neuroendocrinology: the posterior pituitary, from Geoffrey Harris to our present understanding. J Endocrinol. 2015;226(2):T173–T185. doi: 10.1530/JOE-15-0087. [PubMed] [Cross Ref]
5. Douglas AJ, Leng G, Russell JA. The importance of oxytocin mechanisms in the control of mouse parturition. Reproduction. 2002;123(4):543–552. doi: 10.1530/rep.0.1230543. [PubMed] [Cross Ref]
6. Brunton PJ, Russell JA. Endocrine induced changes in brain function during pregnancy. Brain Res. 2010;1364:198–215. doi: 10.1016/j.brainres.2010.09.062. [PubMed] [Cross Ref]
7. Carter CS. Developmental consequences of oxytocin. Physiol Behav. 2003;79(3):383–397. doi: 10.1016/S0031-9384(03)00151-3. [PubMed] [Cross Ref]
8. Kosfeld M, et al. Oxytocin increases trust in humans. Nature. 2005;435(7042):673–676. doi: 10.1038/nature03701. [PubMed] [Cross Ref]
9. Donaldson ZR, Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science. 2008;322(5903):900–904. doi: 10.1126/science.1158668. [PubMed] [Cross Ref]
10. Ebstein RP, Israel S, Lerer E. Arginine vasopressin and oxytocin modulate human social behavior. Ann N Y Acad Sci. 2009;1167:87–102. doi: 10.1111/j.1749-6632.2009.04541.x. [PubMed] [Cross Ref]
11. Higashida H, et al. Oxytocin signal and social behaviour: comparison among adult and infant oxytocin, oxytocin receptor and CD38 gene knockout mice. J Neuroendocrinol. 2010;22(5):373–379. doi: 10.1111/j.1365-2826.2010.01976.x. [PubMed] [Cross Ref]
12. Neumann I, et al. Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events. J Neuroendocrinol. 1996;8(3):227–233. doi: 10.1046/j.1365-2826.1996.04557.x. [PubMed] [Cross Ref]
13. Neumann ID. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol. 2008;20(6):858–865. doi: 10.1111/j.1365-2826.2008.01726.x. [PubMed] [Cross Ref]
14. Onaka T, Takayanagi Y, Yoshida M. Roles of oxytocin neurones in the control of stress, energy metabolism, and social behaviour. J Neuroendocrinol. 2012;24(4):587–598. doi: 10.1111/j.1365-2826.2012.02300.x. [PubMed] [Cross Ref]
15. Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron. 2010;65(6):768–779. doi: 10.1016/j.neuron.2010.03.005. [PMC free article] [PubMed] [Cross Ref]
16. Yoshimura M, Uezono Y, Ueta Y. Anorexia in human and experimental animal models: physiological aspects related to neuropeptides. J Physiol Sci. 2015;65(5):385–395. doi: 10.1007/s12576-015-0386-3. [PubMed] [Cross Ref]
17. Nagasawa M, et al. Social evolution. Oxytocin-gaze positive loop and the coevolution of human-dog bonds. Science. 2015;348(6232):333–336. doi: 10.1126/science.1261022. [PubMed] [Cross Ref]
18. Choleris E, et al. Neuroendocrinology of social information processing in rats and mice. Front Neuroendocrinol. 2009;30(4):4424–4459. doi: 10.1016/j.yfrne.2009.05.003. [PubMed] [Cross Ref]
19. Meyer-Lindenberg A, et al. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12(9):524–538. doi: 10.1038/nrn3044. [PubMed] [Cross Ref]
20. Takayanagi Y, et al. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA. 2005;102(44):16096–16101. doi: 10.1073/pnas.0505312102. [PubMed] [Cross Ref]
21. Jin D, et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature. 2007;446(7131):41–45. doi: 10.1038/nature05526. [PubMed] [Cross Ref]
22. Bourque CW. Activity-dependent modulation of nerve terminal excitation in a mammalian peptidergic system. Trends Neurosci. 1991;14(1):28–30. doi: 10.1016/0166-2236(91)90180-3. [PubMed] [Cross Ref]
23. Katz B. The release of neural substances, Sherrington Lecture. Liverpool: Liverpool University; 1969. p. 47.
24. Augustine GJ, Neher E. Calcium requirements for secretion in bovine chromaffin cells. J Physiol. 1992;450:247–271. doi: 10.1113/jphysiol.1992.sp019126. [PubMed] [Cross Ref]
25. Salmina AB, et al. Integrative neurochemistry and neurobiology of social recognition and behavior analyzed with respect to CD38-dependent brain oxytocin secretion. Curr Top Med Chem. 2013;13(23):2965–2977. doi: 10.2174/15680266113136660211. [PubMed] [Cross Ref]
26. Lopatina O, et al. The roles of oxytocin and CD38 in social or parental behaviors. Front Neurosci. 2013;6:182. doi: 10.3389/fnins.2012.00182. [PMC free article] [PubMed] [Cross Ref]
27. Higashida H, et al. CD38 and its role in oxytocin secretion and social behavior. Horm Behav. 2012;61(3):351–358. doi: 10.1016/j.yhbeh.2011.12.011. [PubMed] [Cross Ref]
28. Higashida H, et al. Social memory, amnesia, and autism: brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38. Neurochem Int. 2012;61(6):828–838. doi: 10.1016/j.neuint.2012.01.030. [PubMed] [Cross Ref]
29. Feldman R et al (2015) Oxytocin pathway genes: evolutionary ancient system impacting on human affiliation, sociality, and psychopathology Biol Psychiatry pii: S0006-3223(15)00656-3 [PubMed]
30. Feldman R, et al. Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes. Biol Psychiatry. 2012;72(3):175–181. doi: 10.1016/j.biopsych.2011.12.025. [PubMed] [Cross Ref]
31. Riebold M, et al. All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from autism spectrum disorder. Mol Med. 2011;17(7–8):799–806. [PMC free article] [PubMed]
32. Lerer E, et al. Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Res. 2010;3(6):293–302. doi: 10.1002/aur.156. [PubMed] [Cross Ref]
33. Guastella AJ, Hickie IB (2015) Oxytocin treatment, circuitry and autism: a critical review of the literature placing oxytocin into the autism context. Biol Psychiatry pii: S0006-3223(15)00543-0 [PubMed]
34. Yamasue H, et al. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci. 2012;32(41):14109–14117. doi: 10.1523/JNEUROSCI.3327-12.2012. [PubMed] [Cross Ref]
35. Ebstein RP. The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav. 2012;61(3):359–379. doi: 10.1016/j.yhbeh.2011.12.014. [PubMed] [Cross Ref]
36. Tobin VA, et al. The effects of apelin on the electrical activity of hypothalamic magnocellular vasopressin and oxytocin neurons and somatodendritic peptide release. Endocrinology. 2008;149(12):6136–6145. doi: 10.1210/en.2008-0178. [PMC free article] [PubMed] [Cross Ref]
37. Bealer SL, Armstrong WE, Crowley WR. Oxytocin release in magnocellular nuclei: neurochemical mediators and functional significance during gestation. Am J Physiol Regul Integr Comp Physiol. 2010;299(2):R452–R458. doi: 10.1152/ajpregu.00217.2010. [PubMed] [Cross Ref]
38. Grinevich V (2015) Assembling the puzzle: pathways of oxytocin signaling in the brain. Biol Psychiatry pii: S0006-3223(15)00351-0 [PubMed]
39. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci. 2006;7(2):126–136. doi: 10.1038/nrn1845. [PubMed] [Cross Ref]
40. Neumann ID. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem Soc Trans. 2007;35(Pt 5):1252–1257. doi: 10.1042/BST0351252. [PubMed] [Cross Ref]
41. Adan RAH, et al. Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization. Endocrinology. 1995;136(9):4022–4028. [PubMed]
42. Freund-Mercier MJ, Stoeckel ME, Klein MJ. Oxytocin receptors on oxytocin neurons: histoautoradiographic detection in the lactating rat. J Physiol (Lond) 1994;480:155–161. doi: 10.1113/jphysiol.1994.sp020349. [PubMed] [Cross Ref]
43. Young LJ, et al. Changes in oxytocin receptor mRNA in rat brain during pregnancy and the effects of estrogen and interleukin-6. J Neuroendocrinol. 1997;9(11):859–865. doi: 10.1046/j.1365-2826.1997.00654.x. [PubMed] [Cross Ref]
44. Ludwig M, Stern J. (2015) Multiple signalling modalities mediated by dendritic exocytosis of oxytocin and vasopressin. Philos Trans R Soc Lond B Biol Sci:370(1672) pii: 20140182 [PMC free article] [PubMed]
45. Richard P, Moos F, Freund-Mercier MJ. Central effects of oxytocin. Physiol Rev. 1991;71(2):331–370. [PubMed]
46. Moos F, et al. Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. J Endocrinol. 1984;102(1):63–72. doi: 10.1677/joe.0.1020063. [PubMed] [Cross Ref]
47. Neumann I, et al. An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats. Endocrinol. 1994;134:141–148. [PubMed]
48. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629–683. [PubMed]
49. Lopatina O, et al. Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-ribose or Ca2+ concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice. Neuropharmacology. 2010;58(1):50–55. doi: 10.1016/j.neuropharm.2009.06.012. [PubMed] [Cross Ref]
50. Lee HC. The cyclic ADP-ribose/NAADP/CD38-signaling pathway: past and present. Messenger. 2012;1(1):16–33. doi: 10.1166/msr.2012.1005. [Cross Ref]
51. Okamoto H, Takasawa S, Akira Sugawara A. The CD38-cyclic ADP-ribose system in mammals: historical background, pathophysiology and perspective. Messenger. 2014;3(1–2):27–34. doi: 10.1166/msr.2014.1032. [Cross Ref]
52. Higashida H, et al. CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism. Biol Pharm Bull. 2011;34(9):1369–1372. doi: 10.1248/bpb.34.1369. [PubMed] [Cross Ref]
53. Lambert RC, et al. A rise in the intracellular Ca2+ concentration of isolated rat supraoptic cells in response to oxytocin. J Physiol (Lond) 1994;478:275–287. doi: 10.1113/jphysiol.1994.sp020249. [PubMed] [Cross Ref]
54. Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev. 2002;82(4):893–922. doi: 10.1152/physrev.00013.2002. [PubMed] [Cross Ref]
55. Endo M. Calcium-induced calcium release in skeletal muscle. Physiol Rev. 2009;9(4):1153–1176. doi: 10.1152/physrev.00040.2008. [PubMed] [Cross Ref]
56. Numa S, et al. Molecular insights into excitation–contraction coupling. Cold Spring Harb Symp Quant Biol. 1990;55:1–7. doi: 10.1101/SQB.1990.055.01.003. [PubMed] [Cross Ref]
57. Boittin FX, et al. Vasodilation by the calcium-mobilizing messenger cyclic ADP-ribose. J Biol Chem. 2003;278(11):9602–9608. doi: 10.1074/jbc.M204891200. [PubMed] [Cross Ref]
58. Higashida H, et al. Overexpression of human CD38/ADP-ribosyl cyclase enhances acetylcholine-induced Ca2+ signalling in rodent NG108-15 neuroblastoma cells. Neurosci Res. 2007;57(3):339–346. doi: 10.1016/j.neures.2006.11.008. [PubMed] [Cross Ref]
59. Sternfeld L, et al. Hormonal control of ADP-ribosyl cyclase activity in pancreatic acinar cells from rats. J Biol Chem. 2003;278(36):33629–33636. doi: 10.1074/jbc.M301043200. [PubMed] [Cross Ref]
60. Graeff RM, et al. Cyclic GMP-dependent and -independent effects on the synthesis of the calcium messengers cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate. J Biol Chem. 1998;273(1):118–125. doi: 10.1074/jbc.273.1.118. [PubMed] [Cross Ref]
61. Kim SY, Cho B, Kim UH. CD38-mediated Ca2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation. J Biol Chem. 2010;285(1):576–582. doi: 10.1074/jbc.M109.076216. [PMC free article] [PubMed] [Cross Ref]
62. Rah SY, et al. Activation of CD38 by interleukin-8 signaling regulates intracellular Ca2+ level and motility of lymphokine-activated killer cells. J Biol Chem. 2005;280(4):2888–2895. doi: 10.1074/jbc.M409592200. [PubMed] [Cross Ref]
63. Kim UH. Multiple enzymatic activities of CD38 for Ca2+ signaling messengers. Messenger. 2014;3(1–2):6–14. doi: 10.1166/msr.2014.1030. [Cross Ref]
64. De Flora A, et al. Autocrine and paracrine calcium signaling by the CD38/NAD+/cyclic ADP-ribose system. Ann N Y Acad Sci. 2004;1028:176–191. [PubMed]
65. Franco L. Paracrine roles of NAD+ and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J Biol Chem. 2001;276(24):21642–21648. doi: 10.1074/jbc.M010536200. [PubMed] [Cross Ref]
66. Zhao YJ, Lam CM, Lee HC. The membrane-bound enzyme CD38 exists in two opposing orientations. Sci Signal. 2012;5(241):ra67. doi: 10.1126/scisignal.2002700. [PubMed] [Cross Ref]
67. Zhao YJ, et al. Determinations of the membrane orientation of a calcium signaling enzyme CD38. Biochim Biophys Acta. 2015;1853(9):2095–2103. doi: 10.1016/j.bbamcr.2014.10.028. [PubMed] [Cross Ref]
68. Higashida H, et al. Sympathetic potentiation of cyclic ADP-ribose formation in rat cardiac myocytes. J Biol Chem. 1999;274(47):33348–33353. doi: 10.1074/jbc.274.47.33348. [PubMed] [Cross Ref]
69. Liu HX, et al. Intracellular calcium concentrations regulated by cyclic ADP-ribose and heat in the mouse hypothalamus. Messenger. 2012;1(2):150–159. doi: 10.1166/msr.2012.1015. [Cross Ref]
70. Faouzi M, Penner R. TRPM2. Handb Exp Pharmacol. 2014;222:403–426. doi: 10.1007/978-3-642-54215-2_16. [PubMed] [Cross Ref]
71. Uchida K, Tominaga M. The role of TRPM2 in pancreatic β-cells and the development of diabetes. Cell Calcium. 2014;56(5):332–339. doi: 10.1016/j.ceca.2014.07.001. [PubMed] [Cross Ref]
72. Beck A, et al. Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. FASEB J. 2006;20(7):962–964. doi: 10.1096/fj.05-5538fje. [PubMed] [Cross Ref]
73. Higashida H, et al. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem Int. 2007;51(2–4):192–199. doi: 10.1016/j.neuint.2007.06.023. [PubMed] [Cross Ref]
74. Nirenberg M, et al. Modulation of synapse formation by cyclic adenosine monophosphate. Science. 1983;222(4625):794–799. doi: 10.1126/science.6314503. [PubMed] [Cross Ref]
75. Amina S, et al. Intracellular calcium elevation induced by extracellular application of cyclic-ADP-ribose or oxytocin is temperature-sensitive in rodent NG108-15 neuronal cells with or without exogenous expression of human oxytocin receptors. J Neuroendocrinol. 2010;22(5):460–466. doi: 10.1111/j.1365-2826.2010.01978.x. [PubMed] [Cross Ref]
76. Ceni C, et al. The CD38-independent ADP-ribosyl cyclase from mouse brain synaptosomes: a comparative study of neonate and adult brain. Biochem J. 2006;395(2):417–426. doi: 10.1042/BJ20051321. [PubMed] [Cross Ref]
77. Higashida C, et al. Dopamine-induced regulation and deregulation of the catabolism of cyclic ADP-ribose, an intrinsic mTOR signal inhibitor, during development in the rodent striatum. Messenger. 2013;2(1–2):33–43. doi: 10.1166/msr.2013.1019. [Cross Ref]
78. Salmina AB, et al. CD38/cyclic ADP-ribose system: a new player for oxytocin secretion and regulation of social behavior. J Neuroendocrinol. 2010;22(5):380–392. doi: 10.1111/j.1365-2826.2010.01970.x. [PubMed] [Cross Ref]
79. Modi ME, Young LJ. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies. Horm Behav. 2012;61(3):340–350. doi: 10.1016/j.yhbeh.2011.12.010. [PMC free article] [PubMed] [Cross Ref]
80. Munesue T, et al. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res. 2010;67(2):181–191. doi: 10.1016/j.neures.2010.03.004. [PubMed] [Cross Ref]
81. Feldman R. Sensitive periods in human social development: new insights from research on oxytocin, synchrony, and high-risk parenting. Dev Psychopathol. 2015;27(2):369–395. doi: 10.1017/S0954579415000048. [PubMed] [Cross Ref]
82. Krol KM, et al. Genetic variation in CD38 and breastfeeding experience interact to impact infantsʼ attention to social eye cues. Proc Natl Acad Sci USA. 2015;112(39):E5434–E5442. doi: 10.1073/pnas.1506352112. [PubMed] [Cross Ref]
83. Chang SC, et al. Are genetic variations in OXTR, AVPR1A, and CD38 genes important to social integration? Results from two large USA cohorts. Psychoneuroendocrinology. 2014;39:257–368. doi: 10.1016/j.psyneuen.2013.09.024. [PMC free article] [PubMed] [Cross Ref]
84. Hovey D, et al. Associations between oxytocin-related genes and autistic-like traits. Soc Neurosci. 2014;9(4):378–386. doi: 10.1080/17470919.2014.897995. [PubMed] [Cross Ref]
85. Ebstein RP, et al. Are retinoids potential therapeutic agents in disorders of social cognition including autism? FEBS Lett. 2011;585(11):1529–1536. doi: 10.1016/j.febslet.2011.05.004. [PubMed] [Cross Ref]
86. Sauer C, et al. Effects of a common variant in the CD38 gene on social processing in an oxytocin challenge study: possible links to autism. Neuropsychopharmacology. 2012;37(6):1474–1482. doi: 10.1038/npp.2011.333. [PMC free article] [PubMed] [Cross Ref]
87. Algoe SB, Way BM. Evidence for a role of the oxytocin system, indexed by genetic variation in CD38, in the social bonding effects of expressed gratitude. Soc Cogn Affect Neurosci. 2014;9(12):1855–1861. doi: 10.1093/scan/nst182. [PMC free article] [PubMed] [Cross Ref]
88. Watanabe T, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. 2015;138(11):3400–3412. doi: 10.1093/brain/awv249. [PubMed] [Cross Ref]

Articles from Springer Open Choice are provided here courtesy of Springer